APA

Ludbrook V. J., Hicks K. J., Hanrott K. E., Patel J. S., Binks M. H., Wyres M. R., Watson J., Wilson P., Simeoni M., Schifano L. A., Reich K. & Griffiths C. E. M. (20170313). Investigation of selective JAK1 inhibitor GSK2586184 for the treatment of psoriasis in a randomized placebo-controlled phase IIa study. : The British journal of dermatology.

Chicago

Ludbrook V J, Hicks K J, Hanrott K E, Patel J S, Binks M H, Wyres M R, Watson J, Wilson P, Simeoni M, Schifano L A, Reich K and Griffiths C E M. 20170313. Investigation of selective JAK1 inhibitor GSK2586184 for the treatment of psoriasis in a randomized placebo-controlled phase IIa study. : The British journal of dermatology.

Harvard

Ludbrook V. J., Hicks K. J., Hanrott K. E., Patel J. S., Binks M. H., Wyres M. R., Watson J., Wilson P., Simeoni M., Schifano L. A., Reich K. and Griffiths C. E. M. (20170313). Investigation of selective JAK1 inhibitor GSK2586184 for the treatment of psoriasis in a randomized placebo-controlled phase IIa study. : The British journal of dermatology.

MLA

Ludbrook V J, Hicks K J, Hanrott K E, Patel J S, Binks M H, Wyres M R, Watson J, Wilson P, Simeoni M, Schifano L A, Reich K and Griffiths C E M. Investigation of selective JAK1 inhibitor GSK2586184 for the treatment of psoriasis in a randomized placebo-controlled phase IIa study. : The British journal of dermatology. 20170313.